An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep15236.pdf
Reference79 articles.
1. Marshall, J. L. Maximum-tolerated dose, optimum biologic dose, or optimum clinical value: dosing determination of cancer therapies. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 30, 2815–2816, 10.1200/JCO.2012.43.4233 (2012).
2. Scharovsky, O. G., Mainetti, L. E. & Rozados, V. R. Metronomic chemotherapy: changing the paradigm that more is better. Current oncology 16, 7–15 (2009).
3. Minturn, J. E. et al. A phase II study of metronomic oral topotecan for recurrent childhood brain tumors. Pediatric blood & cancer 56, 39–44, 10.1002/pbc.22690 (2011).
4. Kummar, S. et al. Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1alpha in advanced solid tumors. Clinical cancer research: an official journal of the American Association for Cancer Research 17, 5123–5131, 10.1158/1078-0432.CCR-11-0682 (2011).
5. Hackl, C. et al. Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models. Gut 62, 259–271, 10.1136/gutjnl-2011-301585 (2013).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives;Pharmaceutics;2023-04-08
2. Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy;Cancers;2022-12-22
3. Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches;Journal of Controlled Release;2021-09
4. Leveraging and manufacturing in vitro multicellular spheroid-based tumor cell model as a preclinical tool for translating dysregulated tumor metabolism into clinical targets and biomarkers;Bioresources and Bioprocessing;2020-07-01
5. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment;Expert Opinion on Drug Discovery;2020-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3